11:12 AM EST, 11/21/2024 (MT Newswires) -- Apollomics ( APLM ) said Thursday it has received shareholders' approval for a 1-for-100 reverse split of its class A ordinary shares.

The biopharmaceutical company's new class A ordinary shares will start trading on a split-adjusted basis on Nasdaq from Monday, it added.

Apollomics ( APLM ) said every 100 outstanding share will be combined into one new share as a result of the reverse share split.

Price: 0.11, Change: -0.04, Percent Change: -25.23